Immune-related Dermatitis

Top drugs studied for this disease

CLINICAL_TRIALS research · 2026-02-09
Clinical Trial Update: Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC) [Phase 2]
Phase 2 trial evaluating healthy-donor microbiome MTP-101-C for steroid-relapse/refractory immune-related adverse events and immune-mediated…